Researchers develop light-activated Parkinson’s drug

News

Author: Simge Eva DoganPublished: 18 July 2018

Prep: Cook: Serves:

A new light-activated drug for treating Parkinson’s has been developed by a research team led by the University of Barcelona, Spain.

The drug – named MRS7145 – is placed within a brain implant and then activated by shining a light on it.

The effect of the newly developed drug was tested on live mice to see if it could improve their motor function. The results – published in ‘Journal of Controlled Release’ – showed that MRS7145 reduced tremors and seizures and improved the mice’s ability to walk.

Professor Francisco Ciruela, researcher at the Faculty of Medicine and Health Sciences of the University of Barcelona, Spain, said he envisaged the drug being administered by smart phones, with “the doctor (controlling) in a precise manner the release of the most efficient dose of the active drug in the place of action”.

For more information on Parkinson’s research please visit the EPDA website.

Last Month

Next Month

Go Back

Share this story

Comments

Global update

Women worldwide pose in their heels for Parkinson’s awareness

Young onset PD awareness campaign ‘Heels On Head Up’

Resources & Tools

Thinking about deep brain stimulation? Read this

A new online hub provides essential DBS info, resources and tools

8 smart Parkinson’s apps you need to try

Smartphone apps that can help track and manage Parkinson's

Can awakening dormant neurons reverse Parkinson’s motor symptoms?

Reawakening dormant neurons could help reverse Parkinson’s motor symptoms, researchers in South Korea have found. While Parkinson’s is typically believed to be caused by neuronal death, a new study – published in ‘Current Biology’ journal – suggests that dormant neurons could be another cause. After completing an animal test – which treated the subjects with two compounds that block dopamine-producing neurons from becoming dormant – the researchers found these neurons to be “awakened”, allowing them to resume dopamine production. The researchers hope that this will lead to a disease-modifying treatment, especially for people in the early stages of Parkinson’s. Hoon Ryu, a senior author of the study and researcher at KIST Brain Science Institute, South Korea, said: “This research refutes the common belief that there is no disease-modifying treatment for Parkinson’s due to its basis on neuronal cell death.”

Parkinson’s could be present from birth, study finds

Parkinson’s may be present from birth in younger people with the condition, new research has found. The study – conducted by Cedars-Sinai Medical Centre, US, and published in ‘Nature Medicine’ journal – used induced stem cells from people with young-onset Parkinson’s, to grow dopamine-producing neurons and observe them for early warning signs of the condition. An abnormal pile-up of protein was found during the neurons’ development, including alpha-synuclein; which occurs in Parkinson’s. The scientists conjecture that Parkinson’s symptoms appear when the pile-up continues over 20 or 30 years. The team also found that the drug PEP005 – currently used against skin precancers – could help treat the condition. Michele Tagliati, vice chair and professor at Cedars-Sinai’s Department of Neurology and the study’s co-author, said: “This exciting new research provides hope that one day we may be able to detect and take early action to prevent this disease in at-risk individuals.”…

Testing saliva can help diagnose Parkinson’s, study finds

A saliva test carried out by doctors may be able to both diagnose Parkinson’s and detect the severity of the condition, according to a recent study published in medical journal ‘Neurological Sciences’. Several indicators of the development of Parkinson’s, including problems in the production of energy, can be easily detected in saliva. As part of the study, carried out by a team from the All India Institute of Medical Sciences, New Delhi, India, saliva samples were collected from 76 patients living with Parkinson’s, and 37 participants with good general health. They found that the saliva of those with Parkinson’s reflected evidence of alteration in neurotransmitters – chemical messengers that allow nerve cells to communicate. The researchers said the test “may highlight the characteristic changes in metabolite levels during the onset of Parkinson’s”.

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Name
This field is for validation purposes and should be left unchanged.

Researchers develop light-activated Parkinson’s drug

News

Author: Simge Eva DoganPublished: 18 July 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Global update

Women worldwide pose in their heels for Parkinson’s awareness

sponsored article

Resources & Tools

Thinking about deep brain stimulation? Read this

Resources & Tools

8 smart Parkinson’s apps you need to try

Can awakening dormant neurons reverse Parkinson’s motor symptoms?

Parkinson’s could be present from birth, study finds

Testing saliva can help diagnose Parkinson’s, study finds

{title}

Subscribe

Researchers develop light-activated Parkinson’s drug

News

Author: Simge Eva DoganPublished: 18 July 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Global update

Women worldwide pose in their heels for Parkinson’s awareness

sponsored article

Resources & Tools

Thinking about deep brain stimulation? Read this

Resources & Tools

8 smart Parkinson’s apps you need to try

Can awakening dormant neurons reverse Parkinson’s motor symptoms?

Parkinson’s could be present from birth, study finds

Testing saliva can help diagnose Parkinson’s, study finds

{title}

Subscribe

Sign in